quinuclidines has been researched along with Day Blindness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sand, PK | 1 |
| Cardozo, L; Chapple, C; Haab, F; Ridder, AM | 1 |
| Russell Taylor, WJ | 1 |
1 review(s) available for quinuclidines and Day Blindness
| Article | Year |
|---|---|
Elevating our therapeutic expectations in overactive bladder.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Constipation; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2004 |
2 trial(s) available for quinuclidines and Day Blindness
| Article | Year |
|---|---|
Long-term open-label solifenacin treatment associated with persistence with therapy in patients with overactive bladder syndrome.
Topics: Constipation; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Multivariate Analysis; Patient Compliance; Patient Satisfaction; Quality of Life; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Time; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2005 |
A comparative determination of side effects associated with the oral use of three anticholinergic-psychotropic drugs.
Topics: Adult; Chlordiazepoxide; Clinical Trials as Topic; Constipation; Fatigue; Female; Gastrointestinal Diseases; Headache; Heart Rate; Humans; Male; Middle Aged; Muscular Diseases; Parasympatholytics; Phenobarbital; Placebos; Propantheline; Quinuclidines; Scopolamine; Sex Factors; Tranquilizing Agents; Urination Disorders; Vision Disorders; Xerostomia | 1970 |